Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 495-504 , July 2009

Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects

Received 13 October 2008 ,Revised 12 February 2009 ,Accepted 12 February 2009.

References 

  1. Mathias CJ, Bergmann SR, Green MA. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin. J Nucl Med. 1995;36:1451–1455
  2. Basken NE, Mathias CJ, Lipka AE, Green MA. Species dependence of [64Cu]Cu-bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins. Nucl Med Biol. 2008;35:281–286
  3. Basken N.E., Mathias C.J., Green M.A., Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals. J Pharm Sci, [in press] (DOI:doi:10.1002/jps.21570).
  4. Ackerman LJ, West DX, Mathias CJ, Green MA. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands. Nucl Med Biol. 1999;26:551–554
  5. Kim JL, Mathias CJ, Green MA. Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals; synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions. J Med Chem. 1997;40:132–136
  6. Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol. 1975;11:824–832
  7. Sudlow G, Birkett DJ, Wade DN. Further characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol. 1976;12:1052–1061
  8. Kragh-Hansen U, Chuang VTG, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull. 2002;25(6):695–704
  9. Tillement JP, Houin G, Zini R, Urien S, Albengres E, Barré J, et al. The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance. In:  Testa B editors. Advances in drug research. vol. 13:London: Academic Press; 1984;p. 59–94
  10. Sjöholm I, Ekman B, Kober A, Ljungstedt-Pahlman I, Seiving B, Sjödin T. Binding of drugs to serum albumin XI: the specificity of three binding sites as studied with albumin immobilized in microparticles. Mol Pharmacol. 1979;16:767–777
  11. In:  Lenter C editors. Geigy scientific tables, Physical chemistry composition of blood hematology somatometric data. vol. 3:Basle, Switzerland: CIBA GEIGY; 1984;p. 136–139
  12. Peters T. All about albumin. San Diego (Calif): Academic Press; 1994;
  13. Panjehshahin MR, Yates MS, Bowmer CJ. A comparison of drug binding sites on mammalian serum albumins. Biochem Pharmacol. 1992;44(5):873–879
  14. Robertson A, Karp W, Broderson R. Comparison of the binding characteristics of serum albumins from various animal species. Dev Pharmacol Ther. 1990;15:106–111
  15. Kosa T, Maruyama T, Otagiri M. Species differences of serum albumins I: drug binding sites. Pharm Res. 1997;14(11):1607–1612
  16. John EK, Green MA. Structure–activity relationships for metal-labeled blood flow tracers: comparison of keto aldehyde bis(thiosemicarbazone)copper(II) derivatives. J Med Chem. 1990;33:1764–1770
  17. http://www.elephants.com
  18. Casella G, Berger R. In: Statistical inference. Pacific Grove (Calif): Duxbury; 2002;p. 240–245
  19. The UniProt Consortium . The universal protein resource. Nucleic Acids Res. 2007;35:D193–D197http://www.uniprot.org
  20. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994;22:4673–4680
  21. Larkin MA, Blackshields G, Brown NP, et al. CLUSTAL W and CLUSTAL X version 2.0. Bioinformatics. 2007;23:2947–2948
  22. Curry S, Mandelkow H, Bricks P, Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat Struct Mol Biol. 1998;5:827–835
  23. Petitpas I, Bhattacharya AA, Twine S, East M, Curry S. Crystal structure analysis of warfarin binding to human serum albumin. J Biol Chem. 2001;276:22804–22809
  24. Ghuman J, Zunszain PA, Petitpas I, Bhattacharya AA, Otagiri M, Curry S. Structural basis of the drug-binding specificity of human serum albumin. J Mol Biol. 2005;353:38–52
  25. SAS, version 9.1.3. Cary (NC): SAS Institute Inc.; 2002–2003;
  26. Fujita T, Iwasa J, Hansch C. A new substituent constant, Π, derived from partition coefficients. J Am Chem Soc. 1964;86:5175–5180

PII: S0969-8051(09)00049-3

doi: 10.1016/j.nucmedbio.2009.02.006

Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 495-504 , July 2009

Article Tools

* Image Usage & Resolution